USA Rare Earth has successfully commissioned its Phase 1a commercial magnet production line at its Stillwater, Oklahoma facility, enabling it to begin fulfilling customer orders for neodymium-iron-boron permanent magnets in Q2 2026. This milestone supports the company's goal to build a secure, Western-aligned rare earth supply chain, reducing reliance on foreign sources. The production process involves advanced powder formation and magnet manufacturing, critical for industries like aerospace, defense, and energy. The facility aims to reach 600 metric tons per annum capacity by Q4 2026, with plans to double capacity by Q1 2027 through Phase 1b expansion.
The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...
Lowey Dannenberg, P.C. is investigating Hims & Hers Health, Inc. for allegedly sharing sensitive user health data, including medical histories and mental health info, with third parties without proper consent. This raises concerns about violations of...
Digital agency 9thCO completed a major digital transformation for DNRS, moving from a fragmented WordPress setup to a unified composable architecture. This upgrade centralizes user management, integrates key business tools like CRM and scheduling, an...
Willis Towers Watson, a global advisory firm, is poised for growth with a 25.3% potential stock upside, driven by new initiatives like KwantSure, a digital insurance sales channel for subcontractors, and a Geospatial Mortality Model to improve pensio...
AngioDynamics reported an 8% revenue increase to $86.6 million in Q4, driven by a 16.7% sales rise in its Med Tech division, notably from NanoKnife and AlphaVac products. H.C. Wainwright raised the price target from $16 to $19 and maintained a Buy ra...
